CCM
JAZZ icon

Cinctive Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cinctive Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.56M Buy
34,686
+28,347
+447% +$4.95M 0.43% 78
2025
Q4 		$1.08M Buy
+6,339
New +$972K 0.06% 274
2025
Q1 		– Sell
-47,765
Closed -$5.88M – 397
2024
Q4 		$5.88M Sell
47,765
-80,382
-63% -$9.47M 0.3% 112
2024
Q3 		$14.3M Buy
+128,147
New +$14M 0.78% 29

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cinctive Capital Management's JAZZ Position: Q1 2026 in Review

Cinctive Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 447% in Q1 2026, buying an estimated $4.95M and bringing the position to 34,686 shares worth $6.56M. The position accounts for 0.43% of the portfolio, ranked #78.

Cinctive Capital Management first reported a position in JAZZ in Q3 2024 and has held it in 4 quarters since. The position peaked at $14.3M in Q3 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Cinctive Capital Management held 34,686 shares of Jazz Pharmaceuticals worth $6.56M as of Q1 2026.
  • Cinctive Capital Management bought 28,347 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.95M.
  • Jazz Pharmaceuticals made up 0.43% of Cinctive Capital Management's portfolio in Q1 2026, its #78 holding.
  • Cinctive Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Cinctive Capital Management's Jazz Pharmaceuticals position peaked at $14.3M in Q3 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.